Soiken Holdings
2385
GIG Works
2375
Note
5243
Renascience
4889
Reyuu Japan
9425
JP Stock MarketDetailed Quotes
4591 Ribomic
- 85
- +1+1.19%
20min DelayMarket Closed Jan 24 15:30 JST
3.55BMarket Cap-2.96P/E (Static)
86High83Low837.50KVolume83Open84Pre Close70.92MTurnover12352wk High2.22%Turnover Ratio41.73MShares6052wk Low-25.7EPS TTM3.21BFloat Cap2078Historical HighLossP/E (Static)37.71MShs Float60Historical Low-28.7EPS LYR3.57%Amplitude--Dividend TTM1.05P/B100Lot Size--Div YieldTTM
Ribomic News
Express News | [Change Report] SMBC Nikko Securities reported that their Shareholding in Recombibody (4591.JP) has decreased to 2.81%.
Express News | [Change Report] SMBC Nikko Securities reported a decrease in Shareholding of Ribomic (4591.JP) to 7.15%.
Stocks that moved the previous day part 2: Liberata, BTM, HPC Systems, ETC.
Stock Name <Code> Closing price on the 9th ⇒ Change from the previous day NISSAN MOTOR CO <7201> 446.5 -20.9 Moves continue with an awareness of the integration discount with Honda. ROHM <6963> 1495.5 -64 Citigroup Securities has lowered the Target Price. Kura Sushi <2695> 2770 -126 The financial results of the U.S. subsidiary were viewed positively. Mitsui High-Tec <6966> 867 -49 There are also profit-taking actions due to the rebound from the stock price rise since the beginning of the year. MAZDA MOTOR CRP <7261> 1048.5
The Tokyo Stock Exchange Growth Index has slightly declined, briefly rising into positive territory but then losing momentum.
Tokyo Stock Exchange Growth Market Index 825.08 -0.46 / Volume 0.1 billion 85.09 million shares / Trading value 134.6 billion yen. Tokyo Stock Exchange Growth Market 250 Index 643.42 -0.25 / Volume 0.1 billion 8.41 million shares / Trading value 101.2 billion yen. Today's growth market saw a slight downturn in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, with 218 stocks rising, 349 stocks declining, and 37 unchanged. Today's growth market experienced a complicated interplay of buying and selling.
Stocks that moved or were traded in the first half of the session.
* Nexstage <3186> 1531 +115 Morgan Stanley MUFG Securities has raised the Target Price. * Tamura Manufacturing <6768> 543 +34 Expectations for expansion of Datacenter demand are being promoted. * Honeys HD <2792> 1721 +1069 - The November quarter is expected to turn to an increase in operating profit. * World <3612> 2611 +157 Upward revision of full-year performance and Dividends estimates. * Take and Give Needs <4331> 1015 +54 Dividends policy.
Ribomic and other ETC [stocks of interest viewed from volume change]
Stock closing prices compared to the previous day Volume *<4558>* Chukyo Pharmaceutical 229,235,302,700 *<4591>* Ribomic 106,233,886,9200 *<3604>* Kawamoto Industry 954,150,115,5400 *<2351>* ASJ 391,453,30500 *<7980>* Shigematsu Manufacturing 828,447,8300 *<3550>* Studio Atao 204,810,6900 *<5110>* Sumitomo Rubbers 1,769.5 20.56 697,600 *<3744>* Saios 39,629,218,500 *<
Eid, Enechange and others [Emerging Markets press release]
Acquired part of the Stocks of DFree, which is involved in the planning, development, and sales of the solution 'DFree' that alleviates the concerns and burdens of Yukaria excretion, and Mitsukari, which develops and operates the HRTech 'Mitsukari' that understands and analyzes the personality and compatibility of each individual to maximize the power of individuals and organizations. Recognized a subsidy benefit of 0.04 billion yen from Enechange as non-operating income. Significant exercise of subscription rights for the 17th subscription rights of Ribomik (with exercise price revision provisions) occurred on the 6th.
The Tokyo Stock Exchange Growth Index continues to rise, with a focus shifting toward interim purchases.
Tokyo Stock Exchange Growth Market Index 825.54 +3.18 / Volume 0.2 billion 1.01 million shares / Trading value 127.6 billion yen. Tokyo Stock Exchange Growth Market 250 Index 643.67 +2.73 / Volume 96.57 million shares / Trading value 94.9 billion yen. Today, the growth market showed a continuation of gains, with the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index both rising. The number of rising stocks was 261, declining stocks numbered 306, and there were 38 unchanged stocks. Today's growth market was strong. The previous day's (7th) USA market was soft.
Emerging Markets stock digest: BTM rebounded for the first time in six days and reached a daily maximum limit, while Ribomic significantly rebounded.
<303A> visumo 2340 -700 stop-limit. After updating the all-time high in the morning, it has shifted to a selling dominance due to a pause in buying. Visumo went public on December 26 last year, debuting at 1,036 yen, which is 34.5% above the offering price (770 yen). Since then, it has continued to hit the daily upper limit, and on the morning of the 8th, it surged to 3,110 yen, nearly three times the debut price. The operating profit Financial Estimates for the fiscal year ending March 2025 is expected to be 0.073 billion yen, which is a 291.8% increase compared to the previous term.
Individual stock information.
Justplan <4287.T> continued to rise for six days, remaining unchanged amid significant gains. A stock buyback limit of 600,000 shares (4.93% of issued shares excluding treasury stock) and a 200 million yen buyback program were established. The acquisition period is from January 8 to July 31. Additionally, 283,700 treasury shares currently held (2.23% of issued shares before retirement) will be retired effective January 15. McDonald's <2702.T> declined continuously. The preliminary monthly revenue for December was announced, showing same-store sales decreased by 0.4% compared to the same month last year, marking the fifth consecutive month of decline.
Ribomic soared sharply, reaching a temporary stop high, with a patent application resulting from joint research with Mitsubishi Corporation Life Sciences.
Ribomic <4591.T> surged, reaching a stop-high of 113 yen at one point, rising by 30 yen. After the close on the 7th, it was announced that the company succeeded in the creation and development of an 'anti-neutrophil elastase aptamer,' which serves as a candidate for Cosmetic raw materials, in joint research with Mitsubishi Corporation Life Sciences <8058.T>. The results were considered significant as the patent application was filed jointly with Mitsubishi Corporation Life Sciences at the patent office. Mitsubishi Corporation Life Sciences deals with food ingredients, health materials, Cosmetic raw materials, etc.
Stocks reaching the upper and lower limits in the first half of the trading session.
■Limit Up <269A> Sapeet <278A> Terra Drone <3604> Kawamoto Sangyo <4591> Ribomic <5247> BTM <6864> NF Holdings ■Limit Down <303A> visumo * Includes temporary limit ups and downs (listed prices).
Hot Stocks Digest (Morning Session): JINSHD, Adastria, Ribomic, ETC.
JINSHD <3046>: 6,800 yen (+420 yen) significantly continues its upward trend. The previous day announced the monthly trends for December. Same-store sales increased by 24.4% compared to the same month last year, marking 23 consecutive months of positive growth and 8 consecutive months of double-digit increases. It seems that high-priced commodities in both lenses and frames have performed well due to the increased inbound demand leading up to the year-end and the effects of the promotional campaign conducted within the month. The continuation of the strong sales momentum is evaluated positively.
Volume change rate ranking (9 AM) ~ Wada Kousan, NF HD, etc. have made the ranking.
In the ranking of Volume change rates, comparing the average Volume over the last five days with the Volume on the distribution day provides insights into the trends of market participants' interests, etc. ■Top Volume change rates [As of January 8, 9:32] (Comparison with the average Volume over the last five days) Stock code Stock name Volume 5-day average Volume Volume change rate Stock price change rate <4591> Ribomic 9360600107185.08327.33% 0.1566% <4558> Chukyo Medical
Ribomic has significantly rebounded, having succeeded in the creation and development of a raw material candidate for Cosmetic, and has filed a patent with Mitsubishi Corporation Life Science.
Significant rebound. It has been announced that a successful creation and development of an "anti-neutrophil elastase aptamer," which is a candidate for Cosmetic raw materials, has been achieved, and a patent application has been submitted to the Japan Patent Office in collaboration with Mitsubishi Corporation Life Sciences (Chiyoda, Tokyo), a subsidiary of Mitsubishi Corporation. Neutrophil elastase is a protein-degrading enzyme secreted by neutrophils, which are important cells in the immune system. In the future, efforts will be made to consider practical applications and aim to expand growth areas such as the Cosmetic market.
Soft tone, with the decline in U.S. stocks and the rise in U.S. long-term interest rates acting as a burden.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to show a weak performance. Yesterday, on the 7th, the U.S. Stocks market saw the Dow Inc drop 178.20 points (-0.42%) to 42,528.36, continuing its decline. The rise of Semiconductors NVIDIA (NVDA) initially drove the market higher in the morning; however, the company's stock later turned downward, becoming a burden on the market. Additionally, the stronger-than-expected JOLT job openings and ISM non-manufacturing index raised concerns that the pace of interest rate cuts may slow, leading to a rise in long-term interest rates.
Eltes, Eltes and others [Emerging Markets Press Release]
Expansion of the shareholder preferential treatment system for Eltes<br/>Joint research and development with Mitsubishi Corporation Life Sciences, which operates a life sciences business involving food ingredients, health materials, and Cosmetics, has completed the creation of a candidate for Cosmetics raw material "anti-neutrophil elastase aptamer" and a joint patent application.
Strong performance, support for stock prices could be attributed to buying for Dividends, ETC.
[Emerging Markets Individual Stock Strategy] Today's Emerging Markets are expected to show a strong performance. The US stock market was closed yesterday, December 25th, due to the Christmas holiday. The major European markets were also closed, leaving few clues, while in the foreign exchange market, the dollar remains at 157.40 yen, continuing to indicate a trend of yen depreciation and dollar strength, providing reassurance in the Tokyo market. Additionally, today is the final trading day for the rights to receive dividends for companies with December fiscal year-end, and buying for dividends and shareholder benefits is expected to support stock prices. Meanwhile, overseas investment
The market is stable, supported by the rise in U.S. stocks, but resistance may be strong at higher levels.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to have a solid performance. Yesterday, on the 24th, in the US Stocks market, the Dow Inc rose by 390.08 dollars (+0.91%) to 43,297.03 dollars, marking four consecutive days of gains. With a shortened trading day ahead of the Christmas holiday, technology stocks continued to be bought, pushing the stock market higher. Expectations for a Christmas rally leading up to the end of the year contributed to increased buying, which helped to expand the gains in the latter part of the day. Today's Emerging Markets are likely to show a dominant buying trend.
Express News | [Amendment Report] SMBC Nikko Securities reported a decrease in shareholding of Ribomic (4591.JP) stock to 7.86%.